Report updated Apr 24, 2026
INR Diary
For patients undergoing long-term anticoagulation therapy who require consistent tracking of medication adherence and INR blood test levels.
Overview · Full Intel report in progress
INR Diary is an established medical app that is a paid app. With a 4.3/5 rating from 6 reviews, it shows polarized user reception.
What is INR Diary?
Current Momentum
v2.4 · 3w ago
IntenseLast updated 23d ago. 5 versions tracked.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalRating Pulse 🇺🇸
What makes this app unique?
What Are The Key Features?
Allows users to log daily blood thinner doses in pills or milligrams, either individually or via bulk dose schemes.
Records INR blood test measurements and visualizes the evolution of these levels over time.
Sends alerts at user-defined times for both daily medication intake and scheduled INR measurements.
Supports the backup of dose and INR data, enabling users to share their medical history with healthcare providers.
How much does it cost?
Who Built It?
Developing specialized utility tools that help individuals manage complex medical therapies and simplify household transitions.
Portfolio
2
Apps
What other apps does Web Factor BV make?
Explore the full Web Factor BV report
Portfolio breakdown, audience, momentum, and every app published by Web Factor BV.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for INR Diary?
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
39 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for INR Diary
Key Takeaways
The app serves as a specialized digital logbook for anticoagulation patients to track medication adherence and blood test trends for clinical review.
Where Is It Heading?
Trend analysis
Available very soon